Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease
Previous studies showed a relationship between lipid oxidation biomarkers from plasma samples and Alzheimer's Disease (AD), constituting a promising diagnostic tool. In this work we analyzed whether these plasma biomarkers could reflect specific brain oxidation in AD. In this work lipid peroxid...
Saved in:
Main Authors: | Carmen Peña-Bautista (Author), Miguel Baquero (Author), Marina López-Nogueroles (Author), Máximo Vento (Author), David Hervás (Author), Consuelo Cháfer-Pericás (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis
by: Carmen Peña-Bautista, et al.
Published: (2020) -
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study
by: Gemma García-Lluch, et al.
Published: (2023) -
Assessment of Lipid Peroxidation in Alzheimer's Disease Differential Diagnosis and Prognosis
by: Laura Ferré-González, et al.
Published: (2022) -
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
by: Carmen Peña-Bautista, et al.
Published: (2021) -
Assessment of Screening Approach in Early and Differential Alzheimer's Disease Diagnosis
by: Laura Ferré-González, et al.
Published: (2021)